Home/Filings/8-K/0001193125-26-014086
8-K//Current report

Cambium Networks Corp 8-K

Accession 0001193125-26-014086

$CMBMCIK 0001738177operating

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 4:05 PM ET

Size

153.9 KB

Accession

0001193125-26-014086

Research Summary

AI-generated summary of this filing

Updated

Cambium Networks Receives Nasdaq Delisting Notice Over Missed Annual Meeting

What Happened
Cambium Networks Corporation (CMBM) filed an 8-K saying it received a Nasdaq Listing Qualifications staff determination on January 9, 2026 that the company’s failure to hold an annual shareholders’ meeting within 12 months of its prior fiscal year end violates Nasdaq Listing Rule 5620(a). Nasdaq notified the company this non-compliance is an additional basis for delisting and that a Hearings Panel will consider the issue. The company was asked to submit its written views by January 16, 2026 and intends to do so. The Determination Letter does not have any immediate effect on the listing or trading of Cambium’s ordinary shares.

Key Details

  • Nasdaq staff sent the Determination Letter on January 9, 2026 citing non-compliance with Nasdaq Listing Rule 5620(a) (Annual Meeting Rule).
  • Cambium must present its views in writing to the Nasdaq Hearings Panel by January 16, 2026.
  • The company is already subject to a compliance plan before the Hearings Panel and expects to meet that plan.
  • Cambium says it will file delinquent periodic reports, then file a proxy and hold its annual meeting during the quarter ended June 30, 2026 if it regains compliance. The Determination Letter does not immediately affect trading.

Why It Matters
A Nasdaq determination that supports delisting could lead to Cambium’s shares being removed from The Nasdaq Global Market. Delisting can make shares harder to buy or sell, reduce liquidity, lower share price, and hamper the company’s ability to raise capital or impact existing contracts that include listing-related rights or penalties. Investors should monitor the company’s regulatory filings for the company’s submission to Nasdaq, progress on filing delinquent reports, and any Hearings Panel decisions.